EUVIMEDEUVIMED entdecken
Open Access

The Intersection between Immune System and Idiopathic Pulmonary Fibrosis—A Concise Review

Hongli Liu, Huachun Cui, Gang Liu

Fibrosis · 2025

DOI: 10.70322/fibrosis.2025.10004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Fibrosis, 2025. Verfasst von Hongli Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idiopathic pulmonary fibrosis (IPF) is marked by progressive alveolar destruction, impaired tissue regeneration, and relentless fibrogenesis, culminating in respiratory failure and death. A diverse array of resident and non-resident cells within the lung contribute to disease pathogenesis. Notably, immune cells, both resident and recruited, respond to cues from sites of lung injury by undergoing phenotypic transitions and producing a wide range of mediators that influence, initiate, or dictate the function, or dysfunction, of key effector cells in IPF pathology, such as alveolar epithelial cells, lung fibroblasts, and capillary endothelial cells. The role of the immune system in IPF has undergone an interesting evolution, oscillating from initial enthusiasm to skepticism, and now to a renewed focus. This shift reflects both the past failures of immune-targeting therapies for IPF and the unprecedented insights into immune cell heterogeneity provided by emerging technologies. In this article, we review the historical evolution of perspectives on the immune system's role in IPF pathogenesis and examine the lessons learned from previous therapeutic failures targeting immune responses. We discuss the major immune cell types implicated in IPF progression, highlighting their phenotypic transitions and mechanisms of action. Finally, we identify key knowledge gaps and propose future directions for research on the immune system in IPF.

Schlagwörter

Stichwörter der Autor:innen

Adaptive immunityClinical trialIPFInnate immunityMacrophage

Autor:innen und Institutionen

  • Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

Förderung

  • NIAID NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Liu, H., Cui, H., & Liu, G. (2025). The Intersection between Immune System and Idiopathic Pulmonary Fibrosis—A Concise Review. Fibrosis. https://doi.org/10.70322/fibrosis.2025.10004

Vancouver

Liu H, Cui H, Liu G. The Intersection between Immune System and Idiopathic Pulmonary Fibrosis—A Concise Review. Fibrosis. 2025. doi:10.70322/fibrosis.2025.10004

BibTeX
@article{Liu2025,
  author = {Liu, Hongli and Cui, Huachun and Liu, Gang},
  title = {The Intersection between Immune System and Idiopathic Pulmonary Fibrosis—A Concise Review},
  journal = {Fibrosis},
  year = {2025},
  doi = {10.70322/fibrosis.2025.10004}
}
Kostenlos starten →